- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Kelly Rogers
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Melissa Call
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Shalin Naik
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor Daniel Gray
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jeanne Tie
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marnie Blewitt
- Professor Matthew Ritchie
- Professor Melanie Bahlo
- Professor Melissa Davis
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Czabotar
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sandra Nicholson
- Professor Sant-Rayn Pasricha
- Professor Seth Masters
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A multi-pronged approach to targeting myeloproliferative neoplasms
- A new paradigm of machine learning-based structural variant detection
- A whole lot of junk or a treasure trove of discovery?
- Advanced imaging interrogation of pathogen induced NETosis
- Analysing the metabolic interactions in brain cancer
- Atopic dermatitis causes and treatments
- Boosting the efficacy of immunotherapy in lung cancer
- Building a cell history recorder using synthetic biology for longitudinal patient monitoring
- Characterisation of malaria parasite proteins exported into infected liver cells
- Deciphering the heterogeneity of the tissue microenvironment by multiplexed 3D imaging
- Defining the mechanisms of thymic involution and regeneration
- Delineating the molecular and cellular origins of liver cancer to identify therapeutic targets
- Developing computational methods for spatial transcriptomics data
- Developing drugs to block malaria transmission
- Developing models for prevention of hereditary ovarian cancer
- Developing statistical frameworks for analysing next generation sequencing data
- Development and mechanism of action of novel antimalarials
- Development of novel RNA sequencing protocols for gene expression analysis
- Discoveries in red blood cell production and function
- Discovering epigenetic silencing mechanisms in female stem cells
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Dissecting mechanisms of cytokine signalling
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- Epigenetic biomarkers of tuberculosis infection
- Epigenetics – genome wide multiplexed single-cell CUT&Tag assay development
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Exploiting the cell death pathway to fight Schistosomiasis
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- How do nutrition interventions and interruption of malaria infection influence development of immunity in sub-Saharan African children?
- Human lung protective immunity to tuberculosis
- Improving therapy in glioblastoma multiforme by activating complimentary programmed cell death pathways
- Innovating novel diagnostic tools for infectious disease control
- Integrative analysis of single cell RNAseq and ATAC-seq data
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigation of a novel cell death protein
- Malaria: going bananas for sex
- Mapping spatial variation in gene and transcript expression across tissues
- Mechanisms of Wnt secretion and transport
- Multi-modal computational investigation of single-cell communication in metastatic cancer
- Nanoparticle delivery of antibody mRNA into cells to treat liver diseases
- Naturally acquired immune response to malaria parasites
- Organoid-based discovery of new drug combinations for bowel cancer
- Organoid-based precision medicine approaches for oral cancer
- Removal of tissue contaminations from RNA-seq data
- Reversing antimalarial resistance in human malaria parasites
- Role of glycosylation in malaria parasite infection of liver cells, red blood cells and mosquitoes
- Screening for novel genetic causes of primary immunodeficiency
- Single-cell ATAC CRISPR screening – Illuminate chromatin accessibility changes in genome wide CRISPR screens
- Spatial single-cell CRISPR screening – All in one screen: Where? Who? What?
- Statistical analysis of single-cell multi-omics data
- Structural and functional analysis of epigenetic multi-protein complexes in genome regulation
- Structural basing for Wnt acylation
- Structure, dynamics and impact of extra-chromosomal DNA in cancer
- Targeted deletion of disease-causing T cells
- Targeting cell death pathways in tissue Tregs to treat inflammatory diseases
- The cellular and molecular calculation of life and death in lymphocyte regulation
- The role of hypoxia in cell death and inflammation
- The role of ribosylation in co-ordinating cell death and inflammation
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding cellular-cross talk within a tumour microenvironment
- Understanding the genetics of neutrophil maturation
- Understanding the roles of E3 ubiquitin ligases in health and disease
- Unveiling the heterogeneity of small cell lung cancer
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to understand malaria invasion and transmission
- Using structural biology to understand programmed cell death
- Validation and application of serological markers of previous exposure to malaria
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Ashley Weir
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jasmine Rou
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Krishneel Prasa
- Lilly Backshell
- Malvika Kharbanda
- Megan Kent
- Naomi Jones
- Pailene Lim
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Sophie Collard
- Wayne Cawthorne
- Wil Lehmann
- Yanxiang Meng
- Zhong Yan Gan
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A generous vision for impactful medical research
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Philanthropy through the power of sisterhood
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- Donors
- WEHI.TV
Immunology

Immunology is the study of the system that protects our body from infections. Problems with the immune system are linked to many serious health conditions. Our immunology researchers are discovering how the immune system functions in health and disease.
Our immunology research
One-third of our research effort is devoted to immunology. Our researchers are:
- Defining the basic functions of immune cells, how these cells develop, and how they are controlled.
- Revealing what goes wrong in immune disorders including inflammation, autoimmunity, immune deficiency, as well as infectious diseases and cancer.
- Developing new treatments for disease based on immune system modification.
What is immunology?
Immunology is the study of the immune system, which is comprised of specialised cells and molecules. These work together to protect our body from infection by bacteria, viruses, parasites and fungi. The immune system can also prevent the formation of some cancers.
Our immune system can stop most microbes from entering the body, and can stifle their growth and spread. Sometimes, the immune system cannot prevent an infection. Some microbes have developed sophisticated strategies to evade the immune system, allowing them to survive and reproduce within the body.
Adaptive versus innate immunity
Our immune system has diverse strategies to prevent infection. The functions of the immune system can be broadly divided into:
Innate immune system: responds rapidly to microbes, but does not alter significantly on repeat exposure. Important aspects of this are:
- Phagocytosis, or engulfment of microbes by cells.
- Triggering inflammation in response to microbes or tissue damage.
- Releasing substances that limit microbial invasion and recruit immune cells.
Adaptive immune system: develops ‘memory’ to microbes, allowing subsequent immune responses to the same microbe to be faster and larger. This immunological memory can last a lifetime.
Important aspects of adaptive immunity are:
- Cells with receptors that recognise specific microbial proteins.
- Antibodies, which are soluble proteins that can bind a specific microbial protein.
Innate immune responses typically occur more rapidly than adaptive responses. The innate and adaptive immune systems have many interactions, and can involve some of the same cells and molecules.
Immune cells
The immune system involves many different types of cells working together. Many of these are ‘white blood cells’ that develop from blood stem cells in the bone marrow.
Our researchers are contributing to the understanding of how immune cells develop and function. In doing this, they have revealed many sub-types of these cells.
Important immune cells include:
Phagocytes
These are innate immune cells that can engulf (phagocytose) microbes or other particles. They are important in triggering inflammation, and some can alert adaptive immune cells to an infection. Important phagocytes include:
- Dendritic cells
- Neutrophils
- Basophils
- Macrophages
Lymphocytes
These cells include adaptive and innate immune components, with many functions in controlling, stimulating and executing immune responses. Long-lived memory lymphocytes are the source of lifelong immunity to certain infections.
The broad types of lymphocytes are:
- B cells, adaptive immune cells that produce antibodies that specifically bind other proteins, such as on the surface of a microbe.
- T cells, adaptive immune cells that are stimulated by dendritic cells or other phagocytes to become activated against a particular microbe.
- Natural killer cells, which can have innate or adaptive roles in eliminating infections, and also killing cancer cells.
Immune molecules
There are many factors released by immune cells that are important for immune reactions. These include:
- Cytokines, hormone-like signalling proteins that allow cells to communicate with each other via cytokine receptors on the cell surface.
- Antibodies, a type of protein released by B cells. Each antibody can bind a specific protein, called the ‘antigen’, with different antigens recognised by different antibodies. This identifies the antigen as ‘foreign’. The binding of an antibody to a microbe can hamper the microbe’s growth and survival.
Control of the immune response
For good health, both innate and adaptive immune responses need to:
- Start and conclude rapidly to minimise damage to the body’s own cells.
- Only occur in situations of genuine danger, in response to an invading microbe. Immune responses to harmless substances or the body’s own tissues causes disease.
The immune system contains many safeguards that regulate its functions. Many strategies are used to prevent harmful immune responses. This includes systems for destroying or silencing potentially harmful cells that could attack the body’s own tissues.
Immune disorders
Usually the immune system can distinguish our own tissues from invading microbes, and respond appropriately, killing the microbes or infected cells but not harming uninfected or otherwise healthy cells. Defective control of the immune response, leading to misdirected, excessive or inadequate immune responses, underly many immune disorders.
Inflammatory disorders occur when the immune system causes excessive inflammation that damages the body. This may be triggered by an infection, such as in rheumatic fever or occur for no known reason, such as in inflammatory bowel disease.
Autoimmunity is a type of inflammatory disorder that occurs when the immune system mistakenly attacks the body’s own tissues. These disorders are caused by lymphocytes or antibodies reacting to the body’s own tissues.
Significant autoimmune diseases include:
Allergy occurs when the immune system over-reacts to harmless factors in our diet or environment.
Immunodeficiency is a weakened immune system. This causes a person to be infected by microbes more easily than a healthy person.
Cancers of the immune system
Occasionally an immune cell develops changes in its genetic material that allow it to grow uncontrollably, and become long-lived. This can lead to cancers of the immune system, such as:
Immunotherapy
The normal functioning of our immune system is vital to our health. Immune cells can also be harnessed to treat disease, a field called immunotherapy. Examples of immunotherapy include:
- Vaccines expose the immune system to substances that closely resemble a particular microbe, allowing the safe development of adaptive immunity. This protects the body from infection when the microbe is later encountered.
- Targeted therapy can use antibodies to specifically bind to disease-causing molecules or cells. Many targeted therapies for cancer are being developed that bind to specific proteins on the cancer cell’s surface. Another strategy is to target immune cell communication molecules (such as cytokines) to enhance or inhibit the strength of response to cancer or autoimmune diseases.
- Immunosuppression turns off the function of immune cells. Most immunosuppressive medications have widespread effects on immune cells, and can perturb protective as well as harmful immune responses.
- Preventive vaccines switch off a harmful immune response by providing signals to the immune system that a substance is not harmful. Our researchers have developed potential preventive vaccines that are in clinical trials for coeliac disease and type 1 diabetes.
Researchers:
Professor Gabrielle Belz discusses the link between eating green leafy vegetables and digestive health.
Frank Macfarlane Burnet was awarded the Nobel Prize in 1960 and is widely acknowledged as the founder of modern immunology. This animation was created to commemorate the 50th anniversary of Burnet's landmark discovery.
Meet our Eureka Prize winning B cell researchers
Our research into how antibody producing cells become long-lived may provide insights into how certain diseases arise.